SAHM Position & Statement Papers
- The high prevalence of obesity in adolescence is a serious public health concern. Longitudinal studies confirm that health consequences of obesity during adolescence track into adulthood, but that these consequences are reduced by successfully decreasing body fat among obese adolescents.
- Recent attention has focused on the use of antidepressant medications in the treatment of depression in children and adolescents. The United States (U.S.) Food and Drug Administration (FDA) has required manufacturers to include a “black box” warning label on antidepressants that alerts health care providers and consumers to an increased risk of suicidal thinking and behavior in children and adolescents being treated with these medications (FDA Public Health Advisory: Suicidality in Children and Adolescents Being Treated with Antidepressant Medications.